Received May 15, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
tired; dizzy; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingrix) for prophylaxis. In MAY-2026, the patient received Shingrix. In MAY-2026, more than a week after receiving Shingrix, the patient experienced tiredness (Verbatim: tired) and dizziness (Verbatim: dizzy). The outcome of the tiredness and dizziness were not reported. It was unknown if the reporter considered the tiredness and dizziness to be related to Shingrix. It was unknown if the company considered the tiredness and dizziness to be related to Shingrix. Additional Information: GSK Receipt Date: 12-MAY-2026 This case was reported by a patient via interactive digital media. The batch number was not provided and we and unable to contact the reporter.